Maria-fernanda Bonilla

Al Maryah Island
Abu Dhabi, AZ, United Arab Emirates

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Diagnostic and Management Challenges in Interferon-γ Release Assay-Positive Patient with Sarcoid Panuveitis from a Non-Endemic Tuberculosis Region.

Diagnostic and Management Challenges in Interferon-γ Release Assay-Positive Patient with Sarcoid Panuveitis from a Non-Endemic Tuberculosis Region.

Journal: Ocular immunology and inflammation

Published: January 07, 2025

Safety and immunogenicity of the NVX-CoV2373 vaccine as a booster in adults previously vaccinated with the BBIBP-CorV vaccine.

Safety and immunogenicity of the NVX-CoV2373 vaccine as a booster in adults previously vaccinated with the BBIBP-CorV vaccine.

Journal: Vaccine

Published: September 26, 2023

Infectious aortic aneurysms: A case report and review of cases from the Middle East and North Africa (MENA) region.

Infectious aortic aneurysms: A case report and review of cases from the Middle East and North Africa (MENA) region.

Journal: IJID regions

Published: August 07, 2023

Japanese encephalitis in a U.S. traveler returning from Vietnam, 2022.

Japanese encephalitis in a U.S. traveler returning from Vietnam, 2022.

Journal: Travel medicine and infectious disease

Published: December 15, 2022

Traveling for heart transplantation and returning with COVID-19: a logistical, clinical, and pharmacotherapeutic challenge from the Middle East.

Traveling for heart transplantation and returning with COVID-19: a logistical, clinical, and pharmacotherapeutic challenge from the Middle East.

Journal: Drugs & therapy perspectives : for rational drug selection and use

Published: November 09, 2020

Pulmonary cavitation: an under-recognized late complication of severe COVID-19 lung disease.

Pulmonary cavitation: an under-recognized late complication of severe COVID-19 lung disease.

Journal: BMC pulmonary medicine

Published: August 19, 2020

Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease.

Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease.

Journal: Medicine

Published: June 13, 2020

Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a.

Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a.

Journal: IDCases

Published: May 08, 2020

Comparison of antimicrobial activity between ceftolozane-tazobactam and ceftazidime-avibactam against multidrug-resistant isolates of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa.

Comparison of antimicrobial activity between ceftolozane-tazobactam and ceftazidime-avibactam against multidrug-resistant isolates of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: March 21, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026